Recent Progress in the Management of Chronic Lymphocytic Leukemia

Apply for Credit     Download PDF     

This activity is no longer available for credit, however its content is still relevant for your educational needs.
Statement of Need
The purpose of this activity is to enhance knowledge concerning the treatment of patients with chronic lymphocytic leukemia (CLL).

Target Audience
This activity was developed for physicians involved in the treatment and management of patients with CLL.

Learning Objectives
At the completion of this activity participants should be able to:
  • Describe the epidemiology of CLL
  • Explain the current treatment regimens for CLL
  • Identify new treatment options for CLL

Disclosure Statement
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial products(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:



Faculty Disclosures
John Densmore, MD, PhD, FACP has received research funding from Keryx, Cephalon, and Bristol-Myers Squibb.


*Content will include non-FDA-approved uses.

Disclaimer
The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.



Faculty
John Densmore, MD, PhD, FACP
Associate Professor of Clinical Internal Medicine
Department of Medicine
Division of Hematology/Oncology
University of Virginia
Charlottesville, VA

Sponsor Statement
This activity is jointly sponsored by Global Education Group and Medical Learning Institute, Inc.

Content development and logistics for this activity provided by Center of Excellence Media, LLC.







Commercial Support Acknowledgement
This activity is supported by an educational grant from Hospira, Inc.



Technology Requirements

Adobe Reader

Adobe Flash Player